Last reviewed · How we verify
NCT03863743: POUR
Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR)
NA trial testing integrated care pathway in Arthroplasty, Replacement, Hip in 164 participants. Status unknown.
5 February 2022
Quick facts
| Lead sponsor | TriHealth Inc. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 164 |
| Start date | 5 February 2019 |
| Primary completion | 5 February 2022 |
| Estimated completion | 5 February 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- integrated care pathway
- physician's standard of care
Conditions studied
- Arthroplasty, Replacement, Hip — all drugs for Arthroplasty, Replacement, Hip →
- Arthroplasty, Replacement, Knee — all drugs for Arthroplasty, Replacement, Knee →
- Urinary Retention — all drugs for Urinary Retention →
Sponsor
TriHealth Inc. — full company profile →
Who can join
18 and older, any sex, with Arthroplasty, Replacement, Hip or Arthroplasty, Replacement, Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective randomized control trial will be conducted at Good Samaritan Hospital and TriHealth Evendale Hospital. Subjects will receive total hip or knee surgery and follow-up via standard care at the discretion of the treating physician or the experimental study arm in which all patients will undergo the integrated care pathway.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03863743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arthroplasty, Replacement, Hip
Currently open trials in the same condition.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT07516795 — Analgesic Efficacy of Continuous S-ESP vs Continuous FICB After Hip Arthroplasty · NA · active not recruiting
- NCT06102811 — Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty · NA · recruiting
- NCT05678101 — TENS for Relief of Postoperative Pain in Orthopedic Patients · NA · active not recruiting
Other TriHealth Inc. trials
Trials by the same sponsor.
- NCT07017920 — Vitamin D and Hypertensive Disorders of Pregnancy · NA · not yet recruiting
- NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
- NCT06958003 — Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime · NA · enrolling by invitation
- NCT06957990 — Evaluation of Music Therapy for Pre-op/Intra-op During Hernia Surgery to Decrease the Need for Narcotics · NA · enrolling by invitation
- NCT06414083 — Histologic Comparison of Ablative Techniques for Endometriosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03863743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TriHealth Inc.
- Last refreshed: 1 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03863743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing